Studies have not investigated the range of BRAF mutations, co-occurring alterations, and their clinical implications across a large set of sequenced genes, nor have there been robust comparisons of BRAF alteration types between adult and pediatric gliomas. This evidence concerns the gene BRAF and central nervous system cancer.